Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/Axl NF κB/Nrf2 axis
Dan‐Qian Chen, Ya‐Long Feng, Lin Chen, et al.
Free Radical Biology and Medicine (2019) Vol. 134, pp. 484-497
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease
Ya‐Long Feng, Gang Cao, Dan‐Qian Chen, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 24, pp. 4961-4978
Open Access | Times Cited: 174
The role and mechanism of histone lactylation in health and diseases
Yumei Xie, Hongxia Hu, Maoting Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 77
Apelin‐13 inhibits ischemia–reperfusion mediated podocyte apoptosis by reducing m‐TOR phosphorylation to enhance autophagy
Xiang Zheng, Dongshan Chen, Jiyue Wu, et al.
The FASEB Journal (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 2
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 136
Melatonin as a potential modulator of Nrf2
Zahra Ahmadi, Milad Ashrafizadeh
Fundamental and Clinical Pharmacology (2019) Vol. 34, Iss. 1, pp. 11-19
Closed Access | Times Cited: 125
Chronic kidney disease: Biomarker diagnosis to therapeutic targets
Yanni Wang, Shixing Ma, Yuanyuan Chen, et al.
Clinica Chimica Acta (2019) Vol. 499, pp. 54-63
Closed Access | Times Cited: 113
Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
Ya‐Long Feng, Dan‐Qian Chen, Nosratola D. Vaziri, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 54-78
Open Access | Times Cited: 112
Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3β/Nrf2 Pathway
Xue Li, Yu Zou, Jia Xing, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-17
Open Access | Times Cited: 106
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
Lin Chen, Dan‐Qian Chen, Jingru Liu, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 3, pp. 1-18
Open Access | Times Cited: 94
Phytochemistry and Pharmacological Activities of Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb
Anzheng Nie, Yanhui Chao, Xiaochuan Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 80
Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
Shanshan Li, Qian Sun, Meng-Ru Hua, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 61
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy
Dan Liu, Lin Chen, Hui Zhao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 108990-108990
Open Access | Times Cited: 66
Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor
Yang Tian, Ya‐Long Feng, Lin Chen, et al.
Critical Reviews in Toxicology (2019) Vol. 49, Iss. 5, pp. 445-460
Closed Access | Times Cited: 61
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
Hui Zhao, Lin Chen, Yang Tian, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 60
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
Liang-Pu Luo, Ping Suo, Lili Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 51
What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
Raymond Vanholder, Sanjay K. Nigám, Stéphane Burtey, et al.
Toxins (2022) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 35
Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms
Yunlai Wang, Ye Feng, Manman Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
Li Song, Wei Zhang, Shiyun Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116039-116039
Open Access | Times Cited: 20
Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy
Yanni Wang, Hua Miao, Xiao-Yong Yu, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 89-106
Closed Access | Times Cited: 16
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
Xiaojun Li, Ping Suo, Yanni Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology
Zhi-yuan Guo, X. Wu, Shui-juan Zhang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 6
Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria
Ya‐Long Feng, Hua Chen, Dan‐Qian Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 9, pp. 2317-2332
Open Access | Times Cited: 44
Nrf-2 as a therapeutic target in acute kidney injury
Seyyedeh Mina Hejazian, Seyed Mahdi Hosseiniyan Khatibi, Abolfazl Barzegari, et al.
Life Sciences (2020) Vol. 264, pp. 118581-118581
Closed Access | Times Cited: 43
Page 1 - Next Page

Scroll to top